21ヒドロキシラーゼ
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/01/25 17:45:27」(JST)
[Wiki en表示]
Steroid 21-monooxygenase |
Identifiers |
EC number |
1.14.99.10 |
CAS number |
9029-68-9 |
Databases |
IntEnz |
IntEnz view |
BRENDA |
BRENDA entry |
ExPASy |
NiceZyme view |
KEGG |
KEGG entry |
MetaCyc |
metabolic pathway |
PRIAM |
profile |
PDB structures |
RCSB PDB PDBe PDBsum |
Gene Ontology |
AmiGO / EGO |
Search |
PMC |
articles |
PubMed |
articles |
NCBI |
proteins |
|
Cytochrome P450, family 21, subfamily A, polypeptide 2 |
Available structures |
PDB |
Ortholog search: PDBe, RCSB |
List of PDB id codes |
2GEG
|
|
|
Identifiers |
Symbols |
CYP21A2; CA21H; CAH1; CPS1; CYP21; CYP21B; P450c21B |
External IDs |
OMIM: 613815 MGI: 88591 HomoloGene: 68063 ChEMBL: 2759 GeneCards: CYP21A2 Gene |
EC number |
1.14.99.10 |
Gene Ontology |
Molecular function |
• steroid 21-monooxygenase activity
• steroid binding
• iron ion binding
• steroid hydroxylase activity
• electron carrier activity
• heme binding
|
Cellular component |
• endoplasmic reticulum membrane
|
Biological process |
• glucocorticoid biosynthetic process
• mineralocorticoid biosynthetic process
• xenobiotic metabolic process
• steroid metabolic process
• small molecule metabolic process
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
|
Entrez |
1589 |
13079 |
|
Ensembl |
ENSG00000198457 |
ENSMUSG00000024365 |
|
UniProt |
P08686 |
P03940 |
|
RefSeq (mRNA) |
NM_000500 |
NM_009995 |
|
RefSeq (protein) |
NP_000491 |
NP_034125 |
|
Location (UCSC) |
Chr 6:
32.01 – 32.01 Mb |
Chr 17:
34.8 – 34.8 Mb |
|
PubMed search |
[1] |
[2] |
|
|
Steroid 21-hydroxylase is a cytochrome P450 enzyme that is involved with the biosynthesis of the steroid hormones aldosterone and cortisol.[1]
In humans, 21-Hydroxylase is encoded by the gene CYP21A2.[2]
Contents
- 1 Names and classification
- 2 Function
- 3 Reaction
- 4 Pathway
- 5 Clinical significance
- 6 References
- 7 Further reading
- 8 External links
Names and classification[edit]
21-Hydroxylase is also called steroid 21-monooxygenase, 21α-Hydroxylase, and, less commonly 21β-Hydroxylase.
Function[edit]
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone.[3]
Reaction[edit]
21-Hydroxylase catalyses the hydroxylation of the carbon atom 21 in steroids (adding an "–OH"), which is necessary with the formation of these hormones.
|
Steroid numbering - #21 is near center top
|
|
Pathway[edit]
Human steroidogenesis, showing both reactions of 21-Hydroxylase at center top.
|
Corticosteroid biosynthetic pathway in the rat.
|
Clinical significance[edit]
A defect within the CYP21A2 gene causes a disturbance of the development of the enzyme, which leads to congenital adrenal hyperplasia due to 21-hydroxylase deficiency. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought account for many cases of steroid 21-hydroxylase deficiency.[3]
References[edit]
- ^ Ryan KJ, Engel LL (March 1957). "Hydroxylation of steroids at carbon 21". J. Biol. Chem. 225 (1): 103–14. PMID 13416221.
- ^ Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y (May 1986). "Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene". Proc. Natl. Acad. Sci. U.S.A. 83 (9): 2841–5. doi:10.1073/pnas.83.9.2841. PMC 323402. PMID 3486422.
- ^ a b "Entrez Gene: CYP21A2 cytochrome P450, family 21, subfamily A, polypeptide 2".
Further reading[edit]
- White PC, Tusie-Luna MT, New MI, Speiser PW (1994). "Mutations in steroid 21-hydroxylase (CYP21).". Hum. Mutat. 3 (4): 373–8. doi:10.1002/humu.1380030408. PMID 8081391.
- Helmberg A (1993). "Twin genes and endocrine disease: CYP21 and CYP11B genes.". Acta Endocrinol. 129 (2): 97–108. PMID 8372604.
- de-Araujo M, Sanches MR, Suzuki LA, et al. (1996). "Molecular analysis of CYP21 and C4 genes in Brazilian families with the classical form of steroid 21-hydroxylase deficiency.". Braz. J. Med. Biol. Res. 29 (1): 1–13. PMID 8731325.
- Yu CY (1999). "Molecular genetics of the human MHC complement gene cluster.". Exp. Clin. Immunogenet. 15 (4): 213–30. doi:10.1159/000019075. PMID 10072631.
- Forest MG, Tardy V, Nicolino M, et al. (2005). "21-Hydroxylase deficiency: an exemplary model of the contribution of molecular biology in the understanding and management of the disease.". Ann. Endocrinol. (Paris) 66 (3): 225–32. PMID 15988383.
External links[edit]
- GeneReviews/NCBI/NIH/UW entry on 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia
- OMIM entry on 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia
- Synthesis of Desoxycorticosterone from Progesterone through 21-Hydroxylase (Image)
- Steroid 21-Hydroxylase at the US National Library of Medicine Medical Subject Headings (MeSH)
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
Oxidoreductases: dioxygenases, including steroid hydroxylases (EC 1.14)
|
|
1.14.11: 2-oxoglutarate |
- Prolyl hydroxylase
- Lysyl hydroxylase
|
|
1.14.13: NADH or NADPH |
- Flavin-containing monooxygenase
- Nitric oxide synthase
- Cholesterol 7 alpha-hydroxylase
- Methane monooxygenase
- 3A4
- Lanosterol 14 alpha-demethylase
|
|
1.14.14: reduced flavin or flavoprotein |
|
|
1.14.15: reduced iron-sulfur protein |
|
|
1.14.16: reduced pteridine (BH4 dependent) |
- Phenylalanine hydroxylase
- Tyrosine hydroxylase
- Tryptophan hydroxylase
|
|
1.14.17: reduced ascorbate |
- Dopamine beta hydroxylase
|
|
1.14.18-19: other |
- Tyrosinase
- Stearoyl-CoA desaturase-1
|
|
1.14.99 - miscellaneous |
- Cyclooxygenase
- Heme oxygenase (HMOX1)
- Squalene monooxygenase
- 17A1
- 21A2
|
|
- B
- enzm
- 1.1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 10
- 11
- 13
- 14
- 15-18
- 2.1
- 3.1
- 4.1
- 5.1
- 6.1-3
|
|
|
|
Metabolism: lipid metabolism – ketones/cholesterol synthesis enzymes/steroid metabolism
|
|
Mevalonate pathway |
To HMG-CoA |
- Acetyl-Coenzyme A acetyltransferase
- HMG-CoA synthase (regulated step)
|
|
Ketogenesis |
- HMG-CoA lyase
- 3-hydroxybutyrate dehydrogenase
- Thiophorase
|
|
To Mevalonic acid |
|
|
To DMAPP |
- Mevalonate kinase
- Phosphomevalonate kinase
- Pyrophosphomevalonate decarboxylase
- Isopentenyl-diphosphate delta isomerase
|
|
Geranyl- |
- Dimethylallyltranstransferase
- Geranyl pyrophosphate
|
|
|
To cholesterol |
To lanosterol |
- Farnesyl-diphosphate farnesyltransferase
- Squalene monooxygenase
- Lanosterol synthase
|
|
7-Dehydrocholesterol path |
- Lanosterol 14α-demethylase
- Sterol-C5-desaturase-like
- 7-Dehydrocholesterol reductase
|
|
Desmosterol path |
- 24-dehydrocholesterol reductase
|
|
|
To Bile acids |
- Cholesterol 7α-hydroxylase
- Sterol 27-hydroxylase
|
|
Steroidogenesis |
To pregnenolone |
|
|
To corticosteroids |
- aldosterone: 18-hydroxylase
- cortisol/cortisone: 17α-hydroxylase
- 11β dehydrogenase
- both: 3β dehydrogenase
- 21α-hydroxylase
- 11β-hydroxylase
|
|
To sex hormones |
To androgens |
- 17α-hydroxylase/17,20 lyase
- 3β dehydrogenase
- 17β dehydrogenase
- 5α reductase
|
|
To estrogens |
|
|
|
Other/ungrouped |
- Steroid metabolism: sulfatase
- sulfotransferase
- Steroidogenic acute regulatory protein
|
|
|
|
mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m
|
k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon
|
m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)
|
|
|
|
noco (d)/cong/tumr, sysi/epon
|
proc, drug (A10/H1/H2/H3/H5)
|
|
|
|
Cytochromes, oxygenases: cytochrome P450 (EC 1.14)
|
|
CYP1 |
|
|
CYP2 |
- A6
- A7
- A13
- B6
- C8
- C9
- C18
- C19
- D6
- E1
- F1
- J2
- R1
- S1
- U1
- W1
|
|
CYP3 (CYP3A) |
|
|
CYP4 |
- A11
- A22
- B1
- F2
- F3
- F8
- F11
- F12
- F22
- V2
- X1
- Z1
|
|
CYP5-20 |
- CYP5 (A1)
- CYP7 (A1, B1)
- CYP8 (A1, B1)
- CYP11 (A1, B1, B2)
- CYP17 (A1)
- CYP19 (A1)
- CYP20 (A1)
|
|
CYP21-51 |
- CYP21 (A2)
- CYP24 (A1)
- CYP26 (A1, B1, C1)
- CYP27 (A1, B1, C1)
- CYP39 (A1)
- CYP46 (A1)
- CYP51 (A1)
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Imaging features of poorly controlled Congenital Adrenal Hyperplasia in Adults.
- Kok HK1, Sherlock M2, Healy NA1, Doody O1, Govender P1, Torreggiani WC1.
- The British journal of radiology.Br J Radiol.2015 Jul 2:20150352. [Epub ahead of print]
- Congenital adrenal hyperplasia (CAH) is a genetic autosomal recessive condition most frequently as a result of a mutation in the 21-hydroxylase enzyme gene. Patients with poorly controlled CAH can manifest characteristic imaging findings as a result of adrenocorticotrophic hormone stimulation or the
- PMID 26133223
- Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study.
- Falhammar H1,2, Frisén L3,4, Linden Hirschberg A5,6, Norrby C7, Almqvist C7,8, Nordenskjöld A6,9,10, Nordenström A6,11.
- The Journal of clinical endocrinology and metabolism.J Clin Endocrinol Metab.2015 Jun 30:JC20152093. [Epub ahead of print]
- CONTEXT: Congenital adrenal hyperplasia (CAH) is lethal in its most severe forms if not treated with glucocorticoids. However, glucocorticoids may increase the risk of cardiovascular and metabolic morbidity.OBJECTIVE: To study cardiovascular and metabolic morbidity in CAH.DESIGN, SETTING AND PARTICI
- PMID 26126207
- Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase-Deficiency: 13 Years of Neonatal Screening and Follow-up in Bavaria.
- Odenwald B1, Dörr HG2, Bonfig W3, Schmidt H4, Fingerhut R5, Wildner M1, Nennstiel-Ratzel U1.
- Klinische Padiatrie.Klin Padiatr.2015 Jun 19. [Epub ahead of print]
- Background: 21-Hydroxylase deficient (21-OHD) classic congenital adrenal hyperplasia (CAH) is a potentially lethal inherited endocrine disorder. It is included in many neonatal screening programs to prevent morbidity and mortality from salt-wasting and to reduce long-term health problems. This paper
- PMID 26090996
Japanese Journal
- Neonatal mass screening for 21-hydroxylase deficiency
- Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
- Non-Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency that Developed into Symptomatic Severe Hyponatremia
Related Links
- Steroid 21-hydroxylase is a cytochrome P450 enzyme that is involved with the biosynthesis of the steroid hormones ... 21-Hydroxylase is also called steroid 21- monooxygenase, 21α-Hydroxylase, and, less commonly 21β-Hydroxylase.
- Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-OH CAH), in all its forms, accounts for over 95% of diagnosed cases of congenital adrenal hyperplasia, and "CAH" in most contexts refers to 21-hydroxylase deficiency.
Related Pictures
★リンクテーブル★
[★]
- 英
- adrenocortical hormone
- 同
- 副腎皮質ステロイド adrenocorticoids
- 関
- 副腎皮質刺激ホルモン放出ホルモン、副腎皮質刺激ホルモン
- ステロイド
- 関
- 副腎、副腎皮質、ステロイド、コルチコステロイド、ステロイドホルモン、コルチコイド。副腎皮質ホルモン剤
種類(主要なもののみ)
- 球状層から分泌される。アルドステロン
- 索状層から分泌される。コルチゾール
- 網状層から分泌される。アンドロステンジオン
臨床関連
- 21-hydroxylaseが正常に機能しないことにより生じる (L.320)
薬理学
副腎皮質から分泌されるホルモン (SP.895)
[★]
- 英
- cortisol
- 同
- コルチゾル
- 関
- 副腎皮質ホルモン、糖質コルチコイド
コルチゾールの合成
コルチゾールの合成に関係する酵素の局在 HBC.446
基準値
- (血漿) 4.0-18.5 μg/dl (臨床検査法提要第32版) ・・・血中コルチゾール
- (尿) 30-100 μg/日 (臨床検査法提要第32版) ・・・尿中コルチゾール
変動
代謝産物
生理作用
- リンパ球↓、好酸球↓、多核白血球↑ (YN.N-15)
[★]
- 英
- 21-hydroxylase
- 同
- ステロイド21水酸化酵素 ステロイド21-水酸化酵素 steroid 21-hydroxylase、21水酸化酵素、21 beta-hydroxylase、ステロイド21-モノオキシゲナーゼ steroid 21-monooxygenase、シトクロムP-450C21 cytochrome P-450C21、CYP21
臨床関連
[★]
非古典的21-水酸化酵素欠損症
[★]
21-ヒドロキシラーゼ欠損症
[★]
21-ヒドロキシラーゼ欠損症
[★]
古典的21-水酸化酵素欠損症